PhRMA Comments to CMS on Plan to Amend Tennessee’s Section 1115 Demonstration

Graphic of two speech bubbles with three dots in each

PhRMA submitted the following comments on Tennessee's plan to amend Section 1115, a plan which requests new flexibilities and certain exemptions for TennCare administrators from federal oversight. PhRMA has grave concerns about the impact the drug-related proposals would have on Medicaid beneficiaries' access to crucial medications, and urges CMS not to approve these elements of Tennessee's proposal.

Graphic of two speech bubbles with three dots in each